Julien Depaus
About
In The Last Decade
Julien Depaus
21 papers receiving 60 citations
Peers
Comparison fields: 5 of 19
- Oncology 48
- Pathology and Forensic Medicine 39
- Genetics 20
- Radiology, Nuclear Medicine and Imaging 13
- Hematology 12
Countries citing papers authored by Julien Depaus
This map shows the geographic impact of Julien Depaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Depaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Depaus more than expected).
Fields of papers citing papers by Julien Depaus
This network shows the impact of papers produced by Julien Depaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Depaus. The network helps show where Julien Depaus may publish in the future.
Co-authorship network of co-authors of Julien Depaus
This figure shows the co-authorship network connecting the top 25 collaborators of Julien Depaus. A scholar is included among the top collaborators of Julien Depaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Depaus. Julien Depaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 0 | |
| 11 | 2 | |
| 12 | 14 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 3 | |
| 17 | Interim Results of Loncastuximab Tesirine Combined with Ibrutinib in Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma (LOTIS-3) | 5 |
| 18 | 3 | |
| 19 | 3 | |
| 20 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.